Breaking News Instant updates and real-time market news.

GILD

Gilead

$80.38

2.01 (2.56%)

10:40
02/07/18
02/07
10:40
02/07/18
10:40

Notable call buying in Gilead Sciences after earnings

Notable call buying in Gilead Sciences after earnings. The stock up $3.25 to $83.63 on results released Tuesday afternoon and following bullish commentary from Citi analysts. One player pays $2.20 per contract for a 9.7K lot of GILD Mar 85 calls. Nearly 11K trade at that line against 6.6K open interest. Feb 85 calls, Feb 9th 83 and Feb 9th 80 calls are next most active. Total volume is lopsided more than 5:1 at 26K calls and 4.7K puts.

  • 12

    Feb

GILD Gilead
$80.38

2.01 (2.56%)

01/30/18
SBSH
01/30/18
UPGRADE
Target $103
SBSH
Buy
Citi upgrades Gilead to Buy with $103 target following tax reform
Citi analyst Robyn Karnauskas upgraded Gilead Sciences to Buy from Neutral and raised her price target for the shares to $103 from $81. The drugmaker closed yesterday up $3.34 to $88.80. Tax reform could lower the company's tax rate to 22% in 2018 versus prior estimates of 28%, Karnauskas tells investors in a research note. The analyst also raised her nonalcoholic steatohepatitis and JAK-1 probability of success estimates to 50% with both Phase 3 trials expected in the next 12 months. Further, Karnauskas expects Gilead's hepatitis C virus business to stabilize by mid-2018.
01/30/18
01/30/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. CVS Health (CVS) upgraded to Strong Buy from Buy at Needham by analyst Kevin Caliendo, who contended that the stock remains underowned and, unlike its peers, yet to rally beyond the expectations of benefits from the tax changes. The analyst says the company's multiple has remained constant despite the expansion in the rest of the pharma services industry, forecasting EPS growth of 8%-10% beyond the modeled $8 per share in 2019. 2. JetBlue (JBLU) upgraded to Overweight from Neutral at JPMorgan by analyst Jamie Bakier who said the company's costs are "gradually coming under control" and its balance sheet is "sound." The analyst also upgraded United Continental (UAL) to Overweight from Underweight, saying the shares are the "cheapest in the sector and among the most washed out, having declined the most from recent highs." 3. Gilead (GILD) upgraded to Buy from Neutral at Citi by analyst Robyn Karnauskas, who said that tax reform could lower the company's tax rate to 22% in 2018 versus prior estimates of 28%. The analyst also raised her nonalcoholic steatohepatitis and JAK-1 probability of success estimates to 50% with both Phase 3 trials expected in the next 12 months. Further, Karnauskas expects Gilead's hepatitis C virus business to stabilize by mid-2018. 4. Intel (INTC) upgraded to Buy from Neutral at Citi by analyst Christopher Danely, who said overly conservative guidance and poor sentiment from years of underperformance should drive estimates and the stock higher in the near term. He believes management's "new habit" of conservative guidance is good for the stock. 5. Albemarle (ALB) upgraded to Buy from Neutral at UBS by analyst John Roberts, who said the stock is down 23% from the November high despite no change to the outlook for lithium. The analyst attributes the pullback to larger scale lithium expansion announcements and raising concerns of potential oversupply. He believes the market is pricing in 10% annual realized price declines for Albemarle over the next few years. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/31/18
JEFF
01/31/18
NO CHANGE
JEFF
Jefferies sees neutral impact on Biotech from State of the Union
Jefferies analyst Michael Yee sees a net neutral impact on Biotech stocks from President Trump's State of the Union speech last night. During the speech, Trump made comments about making lower drug prices a "priority" for the year, Yee tells investors in a research not titled "Drug Pricing Comments Not New or Surprising - But a Reminder of Rhetoric." The President, however, also commented on broader access to novel clinical trial drugs, Yee points out. After a "strong biotech rally" in January, the analyst assumes the sector, "at some point," will have some relative near-term pullback either on uncertainty about Trump commentary or some consolidation. Some of the analyst's Buy-rated names include AbbVie (ABBV), Amgen (AMGN), Eli Lilly (LLY) and Gilead Sciences (GILD).
02/07/18
SBSH
02/07/18
NO CHANGE
Target $105
SBSH
Buy
Gilead should be bought ahead of pipeline catalysts, says Citi
Citi analyst Robyn Karnauskas raised her price target for Gilead Sciences to $105 from $103 following last night's Q4 results. The analyst recommends buying the stock ahead of pipeline catalysts and keeps a Buy rating on the name. The base business seems to be stabilizing while gene therapy could be a potential growth area, Karnauskas tells investors in a post-earnings research note.

TODAY'S FREE FLY STORIES

VIPS

Vipshop

$11.65

0.425 (3.79%)

15:25
06/18/18
06/18
15:25
06/18/18
15:25
Options
Vipshop call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

TFX

Teleflex

$280.29

-1.61 (-0.57%)

15:20
06/18/18
06/18
15:20
06/18/18
15:20
Conference/Events
Teleflex management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Jun

  • 21

    Jun

  • 25

    Jun

  • 26

    Jun

  • 12

    Jul

  • 05

    Sep

GME

GameStop

$14.27

0.355 (2.55%)

15:19
06/18/18
06/18
15:19
06/18/18
15:19
Periodicals
GameStop talks with PE firms after seeing takeover interest, Reuters says »

GameStop is holding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 28

    Jun

OFC

Corporate Office Properties

$27.36

-0.055 (-0.20%)

15:18
06/18/18
06/18
15:18
06/18/18
15:18
Conference/Events
Corporate Office Properties management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
06/18/18
06/18
15:17
06/18/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
06/18/18
06/18
15:16
06/18/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GME

GameStop

$14.27

0.355 (2.55%)

15:11
06/18/18
06/18
15:11
06/18/18
15:11
Hot Stocks
Breaking Hot Stocks news story on GameStop 

GameStop trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 28

    Jun

HDP

Hortonworks

$19.96

0.86 (4.50%)

15:10
06/18/18
06/18
15:10
06/18/18
15:10
Options
Higher call activity in HortonNetworks as shares see relative strength »

Higher call activity in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:10
06/18/18
06/18
15:10
06/18/18
15:10
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

GME

GameStop

$14.29

0.375 (2.69%)

15:08
06/18/18
06/18
15:08
06/18/18
15:08
Hot Stocks
GameStop jumps after Reuters reports on takeover interest »

Shares of GameStop (GME)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 28

    Jun

QTNT

Quotient

$8.33

1.2 (16.83%)

15:08
06/18/18
06/18
15:08
06/18/18
15:08
Conference/Events
Quotient management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

GME

GameStop

$14.30

0.385 (2.77%)

15:06
06/18/18
06/18
15:06
06/18/18
15:06
Periodicals
Breaking Periodicals news story on GameStop »

GameStop talks with PE…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 28

    Jun

GME

GameStop

$14.31

0.395 (2.84%)

15:05
06/18/18
06/18
15:05
06/18/18
15:05
Hot Stocks
Breaking Hot Stocks news story on GameStop »

GameStop trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 28

    Jun

SKX

Skechers

$29.23

-0.2 (-0.68%)

15:05
06/18/18
06/18
15:05
06/18/18
15:05
Options
Skechers call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CME

CME Group

$169.09

-0.7 (-0.41%)

14:55
06/18/18
06/18
14:55
06/18/18
14:55
Conference/Events
CME Group management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 21

    Jun

  • 26

    Jul

BIG

Big Lots

$41.35

0.11 (0.27%)

14:55
06/18/18
06/18
14:55
06/18/18
14:55
Options
Big Lots put volume heavy and directionally bearish »

Bearish flow noted in Big…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SJW

SJW Corp.

$66.69

-0.16 (-0.24%)

, CTWS

Connecticut Water

$65.50

0.5 (0.77%)

14:49
06/18/18
06/18
14:49
06/18/18
14:49
Hot Stocks
SJW sees giving shareholders chance to vote on Connecticut Water deal ASAP »

SJW Group (SJW) commented…

SJW

SJW Corp.

$66.69

-0.16 (-0.24%)

CTWS

Connecticut Water

$65.50

0.5 (0.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTC

PTC

$98.07

3.2 (3.37%)

14:45
06/18/18
06/18
14:45
06/18/18
14:45
Recommendations
PTC analyst commentary  »

PTC price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

OXY

Occidental Petroleum

$84.23

0.9 (1.08%)

14:45
06/18/18
06/18
14:45
06/18/18
14:45
Options
Occidental Petroleum call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETSY

Etsy

$43.86

1.33 (3.13%)

14:41
06/18/18
06/18
14:41
06/18/18
14:41
Recommendations
Etsy analyst commentary  »

Etsy price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

BUD

AB InBev

$96.45

-2.05 (-2.08%)

14:37
06/18/18
06/18
14:37
06/18/18
14:37
Hot Stocks
AB InBev, Kiip launch blockchain mobile ad campaign »

Kiip and AB Inbev…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

GSKY

GreenSky

$24.15

-0.12 (-0.49%)

14:36
06/18/18
06/18
14:36
06/18/18
14:36
Initiation
GreenSky initiated  »

GreenSky initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DXC

DXC Technology

$83.05

-0.805 (-0.96%)

14:34
06/18/18
06/18
14:34
06/18/18
14:34
Hot Stocks
SOLUTIONS 30, DXC sign strategic partnership in Italy »

SOLUTIONS 30 Italia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QD

Qudian

$9.50

0.01 (0.11%)

14:25
06/18/18
06/18
14:25
06/18/18
14:25
Options
Qudian Inc call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:25
06/18/18
06/18
14:25
06/18/18
14:25
General news
More from Bostic: a possible yield curve inversion »

More from Bostic: a…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.